Latest News in the pharma Industry

Biopharma News

Report reveals fall in biomarker approval volumes

Report reveals fall in biomarker approval volumes

27 Nov 2012

Amplion Research's latest report looks at approval trends for biomarker-based IVD tests in the US.

Read more 
Pharma giants shift focus towards biologics

Pharma giants shift focus towards biologics

26 Nov 2012

Biopharmaceuticals and biologics in particular are coming into their own, according to the latest GBI Research report.

Read more 
Bristol-Myers Squibb Foundation's Together on Diabetes™ marks World Diabetes Day

Bristol-Myers Squibb Foundation's Together on Diabetes™ marks World Diabetes Day

20 Nov 2012

The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the second anniversary of its Together on Diabetes™ initiative by issuing the initiative's second annual report and awarding two new grants to partners in India.

Read more 
Sanofi and T1D Exchange to launch worldwide study

Sanofi and T1D Exchange to launch worldwide study

20 Nov 2012

Sanofi (EURONEXT: SAN and NYSE: SNY) and T1D Exchange, a non-profit organization focused on type 1 diabetes, will collaborate on the TEENs registry study.

Read more 
BioCat and ALPCO Diagnostics Sign Exclusive Distribution Agreement

BioCat and ALPCO Diagnostics Sign Exclusive Distribution Agreement

20 Nov 2012

BioCat, a distributor of research reagents and cutting-edge technologies in the fields of genomics, proteomics, and cell biology, announces the signing of an exclusive distribution agreement with ALPCO Diagnostics.

Read more 
Incyte Wins $50M from Lilly as RA Drug Enters Phase III

Incyte Wins $50M from Lilly as RA Drug Enters Phase III

16 Nov 2012

Incyte won a $50 million milestone payment from Eli Lilly tied to formal initiation of the rheumatoid arthritis (RA) Phase III program for baricitinib, Incyte’s oral JAK1/JAK2 inhibitor (formerly INCB28050).

Read more 
Jubilant HollisterStier Wins Parenteral Contracts

Jubilant HollisterStier Wins Parenteral Contracts

15 Nov 2012

Jubilant HollisterStier’s Contract Manufacturing & Services division, a subsidiary of Jubilant Life Sciences, has recently secured more than $100 million in contracts with pharmaceutical companies for the commercial manufacture of multiple sterile...

Read more 
Catalent, Cevec in Cell Line Sales Pact

Catalent, Cevec in Cell Line Sales Pact

15 Nov 2012

Catalent Pharma Solutions and Cevec Pharmaceuticals have entered a commercial cell line sales agreement for recombinant human alpha-1 antitrypsin (hAAT).

Read more 
Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner's proprietary pipeline

Boehringer Ingelheim enters strategic collaboration agreement to support Molecular Partner's proprietary pipeline

13 Nov 2012

Boehringer Ingelheim's biopharmaceutical contract manufacturing business and Molecular Partners have entered into a strategic manufacturing collaboration.

Read more 
Pharma firms choosing to run more phase-IV trials

Pharma firms choosing to run more phase-IV trials

12 Nov 2012

The number of voluntarily initiated phase-IV clinical trials has increased in recent years, a study has found.

Read more 
Novartis to build new biotech centre in Singapore

Novartis to build new biotech centre in Singapore

5 Nov 2012

Novartis is investing more than $500 million in a new facility in Tuas.

Read more 
Impax Labs reports increasing incomes

Impax Labs reports increasing incomes

5 Nov 2012

Sales of Zomig drove income at Impax Laboratories during the third quarter of the year.

Read more